| scholarly article | Q13442814 |
| P50 | author | Bernard Moss | Q822617 |
| Andrea S Weisberg | Q99633775 | ||
| Jeffrey L Americo | Q112131269 | ||
| P2093 | author name string | Gilad Sivan | |
| P2860 | cites work | Dual roles of the mammalian GARP complex in tethering and SNARE complex assembly at the trans-golgi network | Q24316375 |
| EARP is a multisubunit tethering complex involved in endocytic recycling | Q24323269 | ||
| An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge | Q24535956 | ||
| A novel family of phospholipase D homologues that includes phospholipid synthases and putative endonucleases: identification of duplicated repeats and potential active site residues | Q24674165 | ||
| Poxvirus membrane biogenesis | Q26823774 | ||
| The TRAPP complex: insights into its architecture and function | Q27967625 | ||
| Recent advances in retromer biology | Q28308202 | ||
| Retrograde transport from endosomes to the trans-Golgi network | Q29617826 | ||
| Visualization of intracellular movement of vaccinia virus virions containing a green fluorescent protein-B5R membrane protein chimera | Q31905797 | ||
| The small G protein Arl5 contributes to endosome-to-Golgi traffic by aiding the recruitment of the GARP complex to the Golgi | Q33112698 | ||
| High-voltage electron microscope study of the release of vaccinia virus from whole cells | Q33186824 | ||
| Tubular early endosomal networks in AtT20 and other cells | Q33404259 | ||
| Retrograde Trafficking Inhibitor of Shiga Toxins Reduces Morbidity and Mortality of Mice Infected with Enterohemorrhagic Escherichia coli | Q33422946 | ||
| (S)-N-Methyldihydroquinazolinones are the Active Enantiomers of Retro-2 Derived Compounds against Toxins | Q33636183 | ||
| Envelope formation is blocked by mutation of a sequence related to the HKD phospholipid metabolism motif in the vaccinia virus F13L protein | Q33640531 | ||
| Golgi network targeting and plasma membrane internalization signals in vaccinia virus B5R envelope protein | Q33802619 | ||
| Vaccinia virus strain differences in cell attachment and entry | Q37238558 | ||
| Assembly and disassembly of the capsid-like external scaffold of immature virions during vaccinia virus morphogenesis | Q37333931 | ||
| A retrograde trafficking inhibitor of ricin and Shiga-like toxins inhibits infection of cells by human and monkey polyomaviruses | Q37482476 | ||
| ST-246 is a key antiviral to inhibit the viral F13L phospholipase, one of the essential proteins for orthopoxvirus wrapping | Q39046951 | ||
| Deletion of the vaccinia virus F13L gene results in a highly attenuated virus that mounts a protective immune response against subsequent vaccinia virus challenge | Q39433591 | ||
| RNAi screening reveals proteasome- and Cullin3-dependent stages in vaccinia virus infection. | Q39533542 | ||
| Intracellular localization of vaccinia virus extracellular enveloped virus envelope proteins individually expressed using a Semliki Forest virus replicon | Q39585406 | ||
| Endocytosis of adeno-associated virus type 5 leads to accumulation of virus particles in the Golgi compartment | Q39748126 | ||
| Differences between extracellular and intracellular forms of poxvirus and their implications | Q39899305 | ||
| Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment | Q40136590 | ||
| Vaccinia virus intracellular enveloped virions move to the cell periphery on microtubules in the absence of the A36R protein | Q40361701 | ||
| Mechanism of Vaccinia Virus Release and Its Specific Inhibition by N 1 -Isonicotinoyl- N 2 -3-Methyl-4- Chlorobenzoylhydrazine | Q40624159 | ||
| Polypeptide composition of extracellular enveloped vaccinia virus. | Q40626379 | ||
| Movements of vaccinia virus intracellular enveloped virions with GFP tagged to the F13L envelope protein | Q40774404 | ||
| Vaccinia virus utilizes microtubules for movement to the cell surface. | Q40790144 | ||
| Palmitylation of the vaccinia virus 37-kDa major envelope antigen. Identification of a conserved acceptor motif and biological relevance | Q41133889 | ||
| Biochemical analysis of the major vaccinia virus envelope antigen | Q41281759 | ||
| Inhibition of release of vaccinia virus by N1-isonicotinoly-N2-3-methyl-4-chlorobenzoylhydrazine | Q42065571 | ||
| Orthopoxviruses require a functional ubiquitin-proteasome system for productive replication | Q42122542 | ||
| The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence | Q42622915 | ||
| Kinesin-dependent movement on microtubules precedes actin-based motility of vaccinia virus | Q42823574 | ||
| Mutagenesis of the palmitoylation site in vaccinia virus envelope glycoprotein B5. | Q45360490 | ||
| Lipase activities of p37, the major envelope protein of vaccinia virus | Q45758937 | ||
| Actin-based motility of vaccinia virus | Q45772757 | ||
| Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia | Q45790937 | ||
| The COG complex interacts with multiple Golgi SNAREs and enhances fusogenic assembly of SNARE complexes. | Q45980495 | ||
| A targeted siRNA screen to identify SNAREs required for constitutive secretion in mammalian cells. | Q50336118 | ||
| Evidence for a family of archaeal ATPases | Q73101135 | ||
| N-methyldihydroquinazolinone derivatives of Retro-2 with enhanced efficacy against Shiga toxin | Q86446412 | ||
| Vaccinia virus intracellular movement is associated with microtubules and independent of actin tails | Q33849999 | ||
| Vaccinia virus F13L protein with a conserved phospholipase catalytic motif induces colocalization of the B5R envelope glycoprotein in post-Golgi vesicles | Q33852860 | ||
| Mutagenesis of phospholipase D defines a superfamily including a trans-Golgi viral protein required for poxvirus pathogenicity. | Q33887155 | ||
| Inhibition of retrograde transport protects mice from lethal ricin challenge | Q34022109 | ||
| The membrane fusion step of vaccinia virus entry is cooperatively mediated by multiple viral proteins and host cell components | Q34109783 | ||
| The formation and function of extracellular enveloped vaccinia virus | Q34162719 | ||
| Similarities in the induction of post-Golgi vesicles by the vaccinia virus F13L protein and phospholipase D. | Q34343103 | ||
| Progeny vaccinia and human cytomegalovirus particles utilize early endosomal cisternae for their envelopes. | Q34355637 | ||
| Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis | Q34582914 | ||
| Participation of vaccinia virus l2 protein in the formation of crescent membranes and immature virions | Q34742862 | ||
| Transport according to GARP: receiving retrograde cargo at the trans-Golgi network. | Q34777250 | ||
| Syntaxin 5-dependent retrograde transport to the trans-Golgi network is required for adeno-associated virus transduction | Q34991404 | ||
| Vaccinia virus entry into cells via a low-pH-dependent endosomal pathway | Q35024254 | ||
| The COG complex interacts directly with Syntaxin 6 and positively regulates endosome-to-TGN retrograde transport | Q35156980 | ||
| Intracellular trafficking of a palmitoylated membrane-associated protein component of enveloped vaccinia virus | Q35182349 | ||
| Structural optimization of a retrograde trafficking inhibitor that protects cells from infections by human polyoma- and papillomaviruses. | Q35229860 | ||
| Characterization of intracellular and extracellular vaccinia virus variants: N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine interferes with cytoplasmic virus dissemination and release | Q35241371 | ||
| The exit of vaccinia virus from infected cells | Q35965285 | ||
| Delivery into cells: lessons learned from plant and bacterial toxins | Q36091291 | ||
| Safety and pharmacokinetics of the anti-orthopoxvirus compound ST-246 following a single daily oral dose for 14 days in human volunteers | Q36172531 | ||
| Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax | Q36424513 | ||
| Evidence against an essential role of COPII-mediated cargo transport to the endoplasmic reticulum-Golgi intermediate compartment in the formation of the primary membrane of vaccinia virus | Q36541180 | ||
| In a nutshell: structure and assembly of the vaccinia virion | Q36550897 | ||
| Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network. | Q36619094 | ||
| Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination. | Q36651113 | ||
| Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope | Q36687208 | ||
| Role of cell-associated enveloped vaccinia virus in cell-to-cell spread | Q36698801 | ||
| A conserved poxvirus NlpC/P60 superfamily protein contributes to vaccinia virus virulence in mice but not to replication in cell culture | Q36699505 | ||
| A mutation in the gene encoding the vaccinia virus 37,000-M(r) protein confers resistance to an inhibitor of virus envelopment and release | Q36700431 | ||
| Genome-wide siRNA screen identifies the retromer as a cellular entry factor for human papillomavirus. | Q36819964 | ||
| Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein | Q36820928 | ||
| Inhibition of the ubiquitin-proteasome system prevents vaccinia virus DNA replication and expression of intermediate and late genes | Q37110640 | ||
| Vaccinia virus p37 interacts with host proteins associated with LE-derived transport vesicle biogenesis | Q37201070 | ||
| Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246. | Q37204210 | ||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Vaccinia virus | Q1986297 |
| virion | Q1757347 | ||
| P304 | page(s) | 8891-8905 | |
| P577 | publication date | 2016-07-27 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Retrograde Transport from Early Endosomes to the trans-Golgi Network Enables Membrane Wrapping and Egress of Vaccinia Virus Virions | |
| P478 | volume | 90 |
| Q47607959 | A Tyrosine-Based Trafficking Motif of the Tegument Protein pUL71 Is Crucial for Human Cytomegalovirus Secondary Envelopment |
| Q40067856 | CSFV proliferation is associated with GBF1 and Rab2. |
| Q52579616 | Concepts in Light Microscopy of Viruses. |
| Q90403913 | Construction of a Fluorescent Screening System of Allosteric Modulators for the GABAA Receptor Using a Turn-On Probe |
| Q94545194 | Discovery of Retro-1 Analogs Exhibiting Enhanced Anti-vaccinia Virus Activity |
| Q89812491 | Functional dissection of the retrograde Shiga toxin trafficking inhibitor Retro-2 |
| Q92763241 | Golgi Structure and Function in Health, Stress, and Diseases |
| Q92486225 | Inhibition of diverse opportunistic viruses by structurally optimized retrograde trafficking inhibitors |
| Q38711122 | Monkeypox Virus Host Factor Screen Using Haploid Cells Identifies Essential Role of GARP Complex in Extracellular Virus Formation |
| Q55424633 | Origin of the poxviral membrane: A 50-year-old riddle. |
| Q47814785 | Parkinson's disease-associated pathogenic VPS35 mutation causes complex I deficits |
| Q93004406 | Partial Deletion of Glycoprotein B5R Enhances Vaccinia Virus Neutralization Escape while Preserving Oncolytic Function |
| Q83227218 | Retro-2 protects cells from ricin toxicity by inhibiting ASNA1-mediated ER targeting and insertion of tail-anchored proteins |
| Q36372015 | Structurally optimized analogs of the retrograde trafficking inhibitor Retro-2cycl limit Leishmania infections |
| Q41933058 | Tagging of the vaccinia virus protein F13 with mCherry causes aberrant virion morphogenesis |
| Q59350375 | The Ectodomain of the Vaccinia Virus Glycoprotein A34 is Required for Cell Binding by Extracellular Virions and Contains a Large Region Capable of Interaction with the Glycoprotein B5 |
| Q38892423 | Triad of human cellular proteins, IRF2, FAM111A, and RFC3, restrict replication of orthopoxvirus SPI-1 host-range mutants |
| Q38699683 | Vaccinia virus egress mediated by virus protein A36 is reliant on the F12 protein |
| Q51740136 | Vaccinia virus phospholipase protein F13 promotes the rapid entry of extracellular virions into cells. |
| Q37409229 | Vaccinia virus uses retromer-independent cellular retrograde transport pathways to facilitate the wrapping of intracellular mature virions during viral morphogenesis |
Search more.